Fed. Circ. Nixes Injunction On Mylan's Generic Doryx

Law360, New York (December 12, 2011, 3:45 PM EST) -- The Federal Circuit on Monday vacated an injunction barring Mylan Pharmaceuticals Inc. from producing a generic version of oral antibiotic Doryx while Warner Chilcott LLC pursues a patent infringement suit over the company's abbreviated new drug application.

Warner Chilcott filed suit in May 2009, claiming Mylan's plans to market a generic Doryx in 150-milligram delayed-release tablets infringed its patent for the drug, which is used to treat acne. In September, U.S. District Judge William Martini granted Warner's request for a preliminary injunction, finding the Irish drug...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.